MyFinsight
Home
Blog
About
Contact
Download
Download image
Acquired in-process
research and development
$947,862K
Intangible asset
amortization
$654,661K
Share-based compensation
$291,133K
Acquisition accounting
inventory fair value...
$147,948K
Accrued liabilities
$77,096K
Depreciation
$41,636K
Accounts payable
$39,851K
Income taxes payable
$37,224K
Non-cash interest
expense
$32,542K
Prepaid expenses and
other assets
-$29,030K
Other liabilities
$28,018K
Provision for losses on
accounts receivable and...
$19,108K
Other non-cash
transactions
-$3,103K
Net cash provided by
operating activities
$1,355,773K
Effect of exchange
rates on cash and cash...
$6,555K
Canceled cashflow
$993,439K
Net increase
(decrease) in cash and cash...
-$1,020,965K
Canceled cashflow
$1,362,328K
Proceeds from maturity of
investments
$1,360,000K
Proceeds from sale of an
asset
$28,167K
Proceeds from employee
equity incentive and...
$107,863K
Deferred tax benefit
-$444,971K
Net income (loss)
-$356,148K
Accounts receivable
$106,279K
Inventories
$86,041K
Net cash used in
investing activities
-$1,509,913K
Canceled cashflow
$1,388,167K
Net cash provided by
(used in) financing...
-$873,380K
Canceled cashflow
$107,863K
Acquisition of investments
$1,830,275K
Asset acquisition,
net of cash acquired
$858,053K
Acquisition of intangible
assets
$108,500K
Purchases of property,
plant and equipment
$58,752K
Acquired in-process
research and development
$42,500K
Repayments of long-term
debt
$781,000K
Share repurchases
$125,023K
Payment of employee
withholding taxes related to...
$75,220K
Back
Back
Cash Flow
source: myfinsight.com
Jazz Pharmaceuticals plc (JAZZ)
Jazz Pharmaceuticals plc (JAZZ)